+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Vaccine Market 2024-2028

  • PDF Icon

    Report

  • 166 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5304713
1h Free Analyst Time

The market is driven by increase in investments in vaccines segment, public immunization programs funded by governments, and improved public access to information about vaccines

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human vaccine market is forecasted to grow by USD 29.1 bn during 2023-2028, accelerating at a CAGR of 9.49% during the forecast period. The report on the human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in pediatric population, need for novel vaccines for chronic infections, and public immunization programs funded by governments.

The human vaccine market is segmented as below:

By Route Of Administration

  • Intramuscular
  • Subcutaneous
  • Oral

By End-user

  • Pediatrics
  • Adults

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the R and D of novel vaccines as one of the prime reasons driving the human vaccine market growth during the next few years. Also, advancements in vaccine delivery systems and development in nano-particle vaccines will lead to sizable demand in the market.

The report on the human vaccine market covers the following areas:

  • Human vaccine market sizing
  • Human vaccine market forecast
  • Human vaccine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human vaccine market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Group Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., and Sanofi SA. Also, the human vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global human vaccine market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
4.2 Route of Administration Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Intramuscular - Market size and forecast 2023-2028
Exhibit 34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
6.4 Subcutaneous - Market size and forecast 2023-2028
Exhibit 38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
6.5 Oral - Market size and forecast 2023-2028
Exhibit 42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Exhibit 46: Market opportunity by Route of Administration ($ billion)
Exhibit 47: Data Table on Market opportunity by Route of Administration ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Pediatrics - Market size and forecast 2023-2028
Exhibit 52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
7.4 Adults - Market size and forecast 2023-2028
Exhibit 56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
Exhibit 111: Astellas Pharma Inc. - Overview
Exhibit 112: Astellas Pharma Inc. - Product/Service
Exhibit 113: Astellas Pharma Inc. - Key news
Exhibit 114: Astellas Pharma Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 115: AstraZeneca Plc - Overview
Exhibit 116: AstraZeneca Plc - Product/Service
Exhibit 117: AstraZeneca Plc - Key news
Exhibit 118: AstraZeneca Plc - Key offerings
12.5 Bavarian Nordic AS
Exhibit 119: Bavarian Nordic AS - Overview
Exhibit 120: Bavarian Nordic AS - Product/Service
Exhibit 121: Bavarian Nordic AS - Key offerings
12.6 Bharat Biotech Ltd.
Exhibit 122: Bharat Biotech Ltd. - Overview
Exhibit 123: Bharat Biotech Ltd. - Product/Service
Exhibit 124: Bharat Biotech Ltd. - Key news
Exhibit 125: Bharat Biotech Ltd. - Key offerings
12.7 CSL Ltd.
Exhibit 126: CSL Ltd. - Overview
Exhibit 127: CSL Ltd. - Business segments
Exhibit 128: CSL Ltd. - Key offerings
Exhibit 129: CSL Ltd. - Segment focus
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Emergent BioSolutions Inc.
Exhibit 134: Emergent BioSolutions Inc. - Overview
Exhibit 135: Emergent BioSolutions Inc. - Product/Service
Exhibit 136: Emergent BioSolutions Inc. - Key news
Exhibit 137: Emergent BioSolutions Inc. - Key offerings
12.10 GlaxoSmithKline Plc
Exhibit 138: GlaxoSmithKline Plc - Overview
Exhibit 139: GlaxoSmithKline Plc - Business segments
Exhibit 140: GlaxoSmithKline Plc - Key news
Exhibit 141: GlaxoSmithKline Plc - Key offerings
Exhibit 142: GlaxoSmithKline Plc - Segment focus
12.11 Inovio Pharmaceuticals Inc.
Exhibit 143: Inovio Pharmaceuticals Inc. - Overview
Exhibit 144: Inovio Pharmaceuticals Inc. - Product/Service
Exhibit 145: Inovio Pharmaceuticals Inc. - Key news
Exhibit 146: Inovio Pharmaceuticals Inc. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 147: Merck and Co. Inc. - Overview
Exhibit 148: Merck and Co. Inc. - Business segments
Exhibit 149: Merck and Co. Inc. - Key news
Exhibit 150: Merck and Co. Inc. - Key offerings
Exhibit 151: Merck and Co. Inc. - Segment focus
12.13 Mitsubishi Chemical Group Corp.
Exhibit 152: Mitsubishi Chemical Group Corp. - Overview
Exhibit 153: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 155: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Moderna Inc.
Exhibit 156: Moderna Inc. - Overview
Exhibit 157: Moderna Inc. - Product/Service
Exhibit 158: Moderna Inc. - Key offerings
12.15 Pfizer Inc.
Exhibit 159: Pfizer Inc. - Overview
Exhibit 160: Pfizer Inc. - Product/Service
Exhibit 161: Pfizer Inc. - Key news
Exhibit 162: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 163: Sanofi SA - Overview
Exhibit 164: Sanofi SA - Business segments
Exhibit 165: Sanofi SA - Key news
Exhibit 166: Sanofi SA - Key offerings
Exhibit 167: Sanofi SA - Segment focus
12.17 Serum Institute of India Pvt. Ltd.
Exhibit 168: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 169: Serum Institute of India Pvt. Ltd. - Product/Service
Exhibit 170: Serum Institute of India Pvt. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 171: Inclusions checklist
Exhibit 172: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 173: Currency conversion rates for US$
13.4 Research methodology
Exhibit 174: Research methodology
Exhibit 175: Validation techniques employed for market sizing
Exhibit 176: Information sources
13.5 List of abbreviations
Exhibit 177: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits 31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Route of Administration
Exhibits 33: Data Table on Comparison by Route of Administration
Exhibits 34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Route of Administration ($ billion)
Exhibits 47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits 48: Chart on End-user - Market share 2023-2028 (%)
Exhibits 49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by End-user
Exhibits 51: Data Table on Comparison by End-user
Exhibits 52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by End-user ($ billion)
Exhibits 61: Data Table on Market opportunity by End-user ($ billion)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ billion)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Astellas Pharma Inc. - Overview
Exhibits 112: Astellas Pharma Inc. - Product/Service
Exhibits 113: Astellas Pharma Inc. - Key news
Exhibits 114: Astellas Pharma Inc. - Key offerings
Exhibits 115: AstraZeneca Plc - Overview
Exhibits 116: AstraZeneca Plc - Product/Service
Exhibits 117: AstraZeneca Plc - Key news
Exhibits 118: AstraZeneca Plc - Key offerings
Exhibits 119: Bavarian Nordic AS - Overview
Exhibits 120: Bavarian Nordic AS - Product/Service
Exhibits 121: Bavarian Nordic AS - Key offerings
Exhibits 122: Bharat Biotech Ltd. - Overview
Exhibits 123: Bharat Biotech Ltd. - Product/Service
Exhibits 124: Bharat Biotech Ltd. - Key news
Exhibits 125: Bharat Biotech Ltd. - Key offerings
Exhibits 126: CSL Ltd. - Overview
Exhibits 127: CSL Ltd. - Business segments
Exhibits 128: CSL Ltd. - Key offerings
Exhibits 129: CSL Ltd. - Segment focus
Exhibits 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 131: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 134: Emergent BioSolutions Inc. - Overview
Exhibits 135: Emergent BioSolutions Inc. - Product/Service
Exhibits 136: Emergent BioSolutions Inc. - Key news
Exhibits 137: Emergent BioSolutions Inc. - Key offerings
Exhibits 138: GlaxoSmithKline Plc - Overview
Exhibits 139: GlaxoSmithKline Plc - Business segments
Exhibits 140: GlaxoSmithKline Plc - Key news
Exhibits 141: GlaxoSmithKline Plc - Key offerings
Exhibits 142: GlaxoSmithKline Plc - Segment focus
Exhibits 143: Inovio Pharmaceuticals Inc. - Overview
Exhibits 144: Inovio Pharmaceuticals Inc. - Product/Service
Exhibits 145: Inovio Pharmaceuticals Inc. - Key news
Exhibits 146: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits 147: Merck and Co. Inc. - Overview
Exhibits 148: Merck and Co. Inc. - Business segments
Exhibits 149: Merck and Co. Inc. - Key news
Exhibits 150: Merck and Co. Inc. - Key offerings
Exhibits 151: Merck and Co. Inc. - Segment focus
Exhibits 152: Mitsubishi Chemical Group Corp. - Overview
Exhibits 153: Mitsubishi Chemical Group Corp. - Business segments
Exhibits 154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits 155: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits 156: Moderna Inc. - Overview
Exhibits 157: Moderna Inc. - Product/Service
Exhibits 158: Moderna Inc. - Key offerings
Exhibits 159: Pfizer Inc. - Overview
Exhibits 160: Pfizer Inc. - Product/Service
Exhibits 161: Pfizer Inc. - Key news
Exhibits 162: Pfizer Inc. - Key offerings
Exhibits 163: Sanofi SA - Overview
Exhibits 164: Sanofi SA - Business segments
Exhibits 165: Sanofi SA - Key news
Exhibits 166: Sanofi SA - Key offerings
Exhibits 167: Sanofi SA - Segment focus
Exhibits 168: Serum Institute of India Pvt. Ltd. - Overview
Exhibits 169: Serum Institute of India Pvt. Ltd. - Product/Service
Exhibits 170: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Validation techniques employed for market sizing
Exhibits 176: Information sources
Exhibits 177: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global human vaccine market: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Group Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., and Sanofi SA.

Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is R and D of novel vaccines.'

According to the report, one of the major drivers for this market is the increase in pediatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • BioNTech SE
  • CanSino Biologics Inc.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Gradalis Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Mitsubishi Chemical Group Corp.
  • Moderna Inc.
  • Novavax Inc.
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sanofi SA